These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8421594)
1. Chemoradiotherapy of anal carcinoma: tumour response and acute toxicity. Tanum G; Tveit KM; Karlsen KO Oncology; 1993; 50(1):14-7. PubMed ID: 8421594 [TBL] [Abstract][Full Text] [Related]
2. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)]. Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148 [TBL] [Abstract][Full Text] [Related]
3. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients. Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058 [TBL] [Abstract][Full Text] [Related]
4. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. Klas JV; Rothenberger DA; Wong WD; Madoff RD Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561 [TBL] [Abstract][Full Text] [Related]
5. [Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients]. Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Pène F; Schlienger M Cancer Radiother; 2003 Aug; 7(4):237-53. PubMed ID: 12914857 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index. Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225 [TBL] [Abstract][Full Text] [Related]
7. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894 [TBL] [Abstract][Full Text] [Related]
8. Radiochemotherapy for anal carcinoma - effectivity and late toxicity. Mai SK; Grieger J; Lachmann R; Bohrer M; Tiefenbacher U; Wenz F Onkologie; 2002 Feb; 25(1):55-9. PubMed ID: 11893884 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients. Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845 [TBL] [Abstract][Full Text] [Related]
11. [The prognostic factors following the simultaneous radiochemotherapy of anal canal carcinoma in a multicenter series of 139 patients]. Grabenbauer GG; Panzer M; Hültenschmidt B; Döker R; Huber K; Kuhne-Velte HJ; Hutter M; Rühl U; Budach V; Wendt T Strahlenther Onkol; 1994 Jul; 170(7):391-9. PubMed ID: 8052938 [TBL] [Abstract][Full Text] [Related]
12. Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal. Kapp KS; Geyer E; Gebhart FH; Oechs AC; Berger A; Hebenstreit J; Stoeger H Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):997-1005. PubMed ID: 11240240 [TBL] [Abstract][Full Text] [Related]
14. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. Doci R; Zucali R; La Monica G; Meroni E; Kenda R; Eboli M; Lozza L J Clin Oncol; 1996 Dec; 14(12):3121-5. PubMed ID: 8955657 [TBL] [Abstract][Full Text] [Related]
15. Cancer of the anal canal: treatment with chemotherapy and low-dose radiation therapy. Smith DE; Shah KH; Rao AR; Frost DB; Latino F; Anderson PJ; Peddada AV; Kagan AR Radiology; 1994 May; 191(2):569-72. PubMed ID: 8153343 [TBL] [Abstract][Full Text] [Related]
16. EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer. Glynne-Jones R; Meadows H; Wan S; Gollins S; Leslie M; Levine E; McDonald AC; Myint S; Samuel L; Sebag-Montefiore D; Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):119-26. PubMed ID: 18472366 [TBL] [Abstract][Full Text] [Related]
17. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Kachnic LA; Tsai HK; Coen JJ; Blaszkowsky LS; Hartshorn K; Kwak EL; Willins JD; Ryan DP; Hong TS Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):153-8. PubMed ID: 21095071 [TBL] [Abstract][Full Text] [Related]
18. Epidermoid carcinoma of the anal canal: treatment by combined radiation and chemotherapy. Grabenbauer GG; Schneider IH; Gall FP; Sauer R Radiother Oncol; 1993 Apr; 27(1):59-62. PubMed ID: 8327734 [TBL] [Abstract][Full Text] [Related]
19. Combined chemoradiation therapy for anal cancer. A report of 56 cases. Doci R; Zucali R; Bombelli L; Montalto F; Lamonica G Ann Surg; 1992 Feb; 215(2):150-6. PubMed ID: 1546901 [TBL] [Abstract][Full Text] [Related]